IL-10 accelerates re-endothelialization and inhibits post-injury intimal hyperplasia following carotid artery denudation

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Verma, Suresh K ^a   Garikipati, Venkata Naga Srikanth ^a   Krishnamurthy, Prasanna ^c   Khan, Mohsin ^a   Thorne, Tina ^d   Qin, Gangjian ^d   Losordo, Douglas W ^d   Kishore, Raj ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ANIMAL; C57BL MOUSE; CAROTID ARTERY; CELL ADHESION; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; GENETICS; HYPERPLASIA; INTIMA; KNOCKOUT MOUSE; MOUSE; PATHOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; CAROTID ARTERIES; CELL ADHESION; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; HYPERPLASIA; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA;

EID: 85017490560     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147615     Document Type: Article

References (36)

1. McDonald RA, Halliday CA, Miller AM, Diver LA, Dakin RS, Montgomery J, et al. Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation. J Am Coll Cardiol. 2015; 65(21):2314-27. doi: 10.1016/j.jacc.2015.03.549 26022821
2. Chaabane C, Otsuka F, Virmani R, Bochaton-Piallat ML. Biological responses in stented arteries. Cardiovasc Res. 2013; 99(2):353-63. doi: 10.1093/cvr/cvt115 23667187
3. Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J. 2011; 75(6):1287-96. 21532177
4. Roubille F, Busseuil D, Shi Y, Nachar W, Mihalache-Avram T, Mecteau M, et al. The interleukin-1beta modulator gevokizumab reduces neointimal proliferation and improves reendothelialization in a rat carotid denudation model. Atherosclerosis. 2014; 236(2):277-85. doi: 10.1016/j.atherosclerosis.2014. 07.012 25108619
5. Colombo A, Sangiorgi G. The monocyte: the key in the lock to reduce stent hyperplasia? J Am Coll Cardiol. 2004; 43(1):24-6. 14715177
6. Kibos A, Campeanu A, Tintoiu I. Pathophysiology of coronary artery in-stent restenosis. Acute Card Care. 2007; 9(2):111-9. 17573586
7. Rajasingh J, Bord E, Luedemann C, Asai J, Hamada H, Thorne T, et al. IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J. 2006; 20(12):2112-4. 16935932
8. Kishore R, Luedemann C, Bord E, Goukassian D, Losordo DW. Tumor necrosis factor-mediated E2F1 suppression in endothelial cells: differential requirement of c-Jun N-terminal kinase and p38 mitogenactivated protein kinase signal transduction pathways. Circ Res. 2003; 93(10):932-40. 14576193
9. Kishore R, Spyridopoulos I, Luedemann C, Losordo DW. Functionally novel tumor necrosis factoralpha-modulated CHR-binding protein mediates cyclin A transcriptional repression in vascular endothelial cells. Circ Res. 2002; 91(4):307-14. 12193463
10. Krasinski K, Spyridopoulos I, Kearney M, Losordo DW. In vivo blockade of tumor necrosis factor-alpha accelerates functional endothelial recovery after balloon angioplasty. Circulation. 2001; 104(15):1754-6. 11591609
11. Murayama H, Takahashi M, Takamoto M, Shiba Y, Ise H, Koyama J, et al. Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury. Cardiovasc Res. 2008; 80(2):175-80. doi: 10.1093/cvr/cvn250 18791204
12. Verma SK, Krishnamurthy P, Barefield D, Singh N, Gupta R, Lambers E, et al. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB. Circulation. 2012; 126(4):418-29. doi: 10.1161/CIRCULATIONAHA.112.112185 22705886
13. Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res. 2009; 104(2):e9-18. doi: 10.1161/CIRCRESAHA.108.188243 19096025
14. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res. 1999; 85(8):e17-24. 10521249
15. De Haro J, Esparza L, Bleda S, Varela C, Sanchez C, Acin F. Attenuation of early atherosclerotic lesions by immunotolerance with beta2 glycoprotein I and the immunomodulatory effectors interleukin 2 and 10 in a murine model. J Vasc Surg. 2014;
16. Shah N, Kammermeier J, Elawad M, Glocker EO. Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease. Curr Allergy Asthma Rep. 2012; 12(5):373-9. doi: 10.1007/s11882-012-0286-z 22890722
17. Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, Aikawa R, et al. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation. 2003; 108(25):3115-21. 14676142
18. Kishore R, Qin G, Luedemann C, Bord E, Hanley A, Silver M, et al. The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A. J Clin Invest. 2005; 115(7):1785-96. 15965500
19. Henglein B, Chenivesse X, Wang J, Eick D, Brechot C. Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci U S A. 1994; 91(12):5490-4. 8202514
20. Indolfi C, Pavia M, Angelillo IF. Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis). Am J Cardiol. 2005; 95(10):1146-52. 15877984
21. Douglas G, Van Kampen E, Hale AB, McNeill E, Patel J, Crabtree MJ, et al. Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification. Eur Heart J. 2013; 34(43):3378-88. doi: 10.1093/eurheartj/ehs240 23008511
22. Yoneda S, Abe S, Kanaya T, Oda K, Nishino S, Kageyama M, et al. Late-phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation. Coron Artery Dis. 2013; 24 (5):368-73. doi: 10.1097/MCA.0b013e32836222ec 23744617
23. Hancock WW, Adams DH, Wyner LR, Sayegh MH, Karnovsky MJ. CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. Am J Pathol. 1994; 145(5):1008-14. 7977633
24. Maffia P, Grassia G, Di Meglio P, Carnuccio R, Berrino L, Garside P, et al. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury. Circulation. 2006; 114(5):430-7. 16864728
25. Moore KW O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol. 1993; 11:165-90. 8386517
26. Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010; 21(5):331-44. doi: 10.1016/j.cytogfr.2010.09.002 21115385
27. Kishore R, Tebo JM, Kolosov M, Hamilton TA. Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. J Immunol. 1999; 162(5):2457-61. 10072482
28. Biswas R, Datta S, Gupta JD, Novotny M, Tebo J, Hamilton TA. Regulation of chemokine mRNA stability by lipopolysaccharide and IL-10. J Immunol. 2003; 170(12):6202-8. 12794151
29. Krishnamurthy P, Lambers E, Verma S, Thorne T, Qin G, Losordo DW, et al. Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice. FASEB J. 2010; 24(7):2484-94. doi: 10.1096/fj.09-149815 20219984
30. Zymek P, Nah DY, Bujak M, Ren G, Koerting A, Leucker T, et al. Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling. Cardiovasc Res. 2007; 74(2):313-22. 17188669
31. Feldman LJ, Aguirre L, Ziol M, Bridou JP, Nevo N, Michel JB, et al. Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation. 2000; 101 (8):908-16. 10694531
32. Chen JP. Safety and efficacy of the drug-eluting stent: a double-edged sword? South Med J. 2008; 101 (2):174-8. doi: 10.1097/01.smj.0000286752.67205.e0 18364620
33. Slottow TL, Waksman R. Drug-eluting stent safety. Am J Cardiol. 2007; 100(8B):10M-7M. 17950827
34. Gasparyan AY, Watson T, Lip GY. The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am Coll Cardiol. 2008; 51(19):1829-43. doi: 10.1016/j.jacc.2007.11.080 18466797
35. Luedemann C, Bord E, Qin G, Zhu Y, Goukassian D, Losordo DW, et al. Ethanol modulation of TNFalpha biosynthesis and signaling in endothelial cells: synergistic augmentation of TNF-alpha mediated endothelial cell dysfunctions by chronic ethanol. Alcohol Clin Exp Res. 2005; 29(6):930-8. 15976518
36. Donato AJ, Morgan RG, Walker AE, Lesniewski LA. Cellular and molecular biology of aging endothelial cells. J Mol Cell Cardiol. 2015;